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Abstract
Systemic administration of polyinosinic:polycytidylic acid (poly I:C), mimics virally-induced activation of TLR3 signalling
causing acute small intestine damage, but whether and how mucosal administration of poly I:C causes enteropathy is less
clear. Our aim was to investigate the inflammatory pathways elicited after intraluminal administration of poly I:C and
determine acute and delayed consequences of this locally induced immune activation. Intraluminal poly I:C induced rapid
mucosal immune activation in C57BL/6 mice involving IFNb and the CXCL10/CXCR3 axis, that may drive inflammation
towards a Th1 profile. Intraluminal poly I:C also caused enteropathy and gut dysfunction in gliadin-sensitive NOD-DQ8 mice,
and this was prolonged by concomitant oral administration of gliadin. Our results indicate that small intestine pathology
can be induced in mice by intraluminal administration of poly I:C and that this is exacerbated by subsequent oral delivery of
a relevant dietary antigen.
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Introduction
Detection of components of microorganisms by a complex
system of pattern recognition receptors leads to immune host
defense. In the gut, home to 1013–1014 resident bacteria, but also
fungi and viruses, the immune mechanisms elicited have a critical
role in tissue homeostasis[1]. However, uncontrolled activation of
these pathways may lead to pathology, as demonstrated in studies
using intraperitoneal (ip) administration of double stranded RNA
(dsRNA) that induces overactivation of TLR3 signalling [2,3,4,5].
Polyinosinic:polycytidylic acid (poly I:C) is a synthetic analogue of
dsRNA used to mimic the intermediates of replication present in
cells infected with RNA viruses and some DNA viruses [6]. In
addition to TLR3, dsRNA sensors include two cytoplasmic
receptors, retinoic acid-inducible gene I (RIG-I) and melanoma
differentiation-associated gene 5 (MDA5) [7]. NFkB and IRF3/7
are the dominant nuclear factors involved in the control of the
expression of inflammatory cytokines and chemokines and Type I
IFN, respectively, upon activation by dsRNA[8]. McAllister C.
et al.5 showed that signaling pathways activated through dsRNA
sensors and particularly, TLR3/TRIF/caspase 8, drive intestinal
pathology but also host protection during viral infection. However,
the role of locally induced, rather than systemic pathways in these
models, remain unclear. More importantly there is a scarcity of
models directly relevant to small intestinal induction of pathology
and gut dysfunction.
Epidemiological studies support the association of enteric
infections with the subsequent development of inflammatory or
functional gastrointestinal disease [9,10]. Viral infections, in
particular enterovirus such as rotavirus, have been suggested to
increase the incidence of celiac disease (CD), a permanent
intolerance to gluten that occurs in genetically susceptible people
[11,12]. Case reports have also suggested the association of enteric
infections with CD onset [13]. Currently, the underlying
mechanisms that support this association are poorly understood.
However, it is well known that innate immune activation generates
a rapid and strong anti-viral response, which essentially involves
the production of Type I IFNs and other components of the
inflammatory response. The link among enterovirus infection and
CD raises the hypothesis that Type I IFNs may be involved in loss
of tolerance to gluten through the ability to promote inflammation
and an strong Th1 response [14].
In this work, we aimed to mimic the local intestinal immune
response as triggered by enteric viral infection. We used
intraluminal administration of poly I:C to wild type mice and
evaluated the immediate in vivo immune and pathological
mechanisms triggered at the small intestinal mucosa. We also
investigated the potential influence of this initial immune
activation on long lasting gut functional responses to administra-
tion of a relevant dietary antigen. For this, we used NOD-DQ8
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mice, a model that allows in vivo evaluation of functional and
immune responses to gliadin, the storage protein in cereals [15].
Animal models rarely recapitulate the full spectrum of human
complex diseases. Moreover, human diseases often express
different clinical phenotypes. Thus the usefulness of animal models
resides in mimicking certain aspects of disease pathogenesis in
order to generate hypotheses to be tested in clinical trials. In this
work, we used two animal models to investigate two different
questions. First, the effect of oral poly I:C in the early stages of the
mucosal innate immune response, and second the influence of the
administration of a specific dietary antigen in preconditioned
mice. We observed that luminal administration of poly I:C
activated the innate immune response and caused acute enterop-
athy. Administration of gliadin to gliadin-sensitive mice previously
treated with poly I:C, prolonged gliadin-induced gut dysfunction.
We propose a mucosally-driven model of enteropathy by poly I:C
in which post inflammatory mechanisms of gastrointestinal disease
can be investigated.
Materials and Methods
Mice
Eight-week female C57BL/6J mice were purchased to the
Animal Care Facility of the Faculty of Exact and Natural Sciences
of the University of Buenos Aires. Mice were housed in plastic
cages and fed ad libitum with balanced food and water. They were
maintained on a 12h light/darkness cycle and acclimatized to the
surrounding conditions for 1 week before the experimental
procedure.
Transgenic mice that express HLA-DQ8 in an endogenous
MHC class II-deficient background were backcrossed to NOD
mice for 10 generations and intercrossed to produce congenic
NOD ABu DQ8 mice [16]. Eight- to 10-wk-old male mice were
used for experiments. Mice were weaned and maintained on a
low-fat (4.4%), gluten-free diet. The original breeding pairs of
NOD-DQ8 mice were kindly provided by Dr. Chella David and
Dr. Joseph Murray from Mayo Clinic, Rochester, USA, and
subsequently bred in specific pathogen-free conditions at McMas-
ter University.
All the studies were performed in accordance with international
protocols for laboratory animal care (Canadian Council on
Animal Care). Experiments were conducted with approval from
the McMaster University Animal Care Committee and the
National University of La Plata Ethic Committee.
Poly I:C treatment and oral gavage
Mice were kept on the gluten free diet at the time of the surgery.
Poly I:C (Sigma-Aldrich) or PBS was intraluminally administrated
throughout an intestinal microsurgery that allows inject the stimuli
directly in the lumen of small intestine. Mice were anaesthetized
with Ketamine 80 mg/kg of weight and Xilacine 10 mg/kg of
weight. Once mice were asleep, 30mg/g of weight of poly I:C
solution in PBS were injected in the lumen of small intestine, 2 cm
after the stomach, to avoid the enzymatic degradation of the poly
I:C (mainly because of nuclease activity from pancreatic enzymes).
Control mice receipted only PBS in the lumen. After the surgery, a
fluid replacement was done and mice were strictly monitored until
they were able to walk around the cage.
A group of mice was sacrificed after 3h or 12h post-treatment
with poly I:C or PBS, and samples of blood and small intestine
were collected for further analysis.
Other group of mice was orally gavaged with 5 mg of a-gliadin/
time, three times a week during 2 weeks, starting at 24h post-
surgery. a-Gliadin (by Sigma-Aldrich) was dissolved in endotoxin-
free acetic acid 0.02 M. Control mice were gavaged with the acetic
acid solution only (Gluten-free diet mice). All solutions were
controlled and endotoxin free preparations were determined using
E-TOXATE endotoxin kit (Sigma). Mice were weighed three
times a week during the 2 weeks, after the oral gavage.
Histologic evaluation
Cross-sections of the proximal small intestine were fixed in 10%
formalin, embedded in paraffin, and stained with H&E staining for
histological evaluation by using a Nikon Eclipse Ti fluorescence
microscope with X-Cites Series 120 Q light source. Images were
taken with Nikon Digital Sight DS Ri1 camera using Nis-Elements
software and measurements were performed using Image J
software properly calibrated.
Two sections of the proximal small intestine were evaluated for
evidence of inflammation. At least thirty villus-to-crypt ratios were
measured for each mouse in a blinded fashion. Intraepithelial
lymphocytes (IELs) per 30 enterocytes in ten randomly chosen
villus tips were counted according to the previously described
methods and expressed as IEL/100 enterocytes [17]. Histological
scores were obtained from the small intestinal sections stained with
H&E, following the Park-Chiu criteria[18]: 0, normal mucosa; 1,
subepithelial space at villus tips; 2, extension of subepithelial space
with moderate lifting; 3, massive lifting down sides of villi, some
denuded tips; 4, denuded villi, dilated capillaries; 5, disintegration
of lamina propria; 6, Crypt layer injury; 7, transmucosal infarction;
8, transmural infarction.
Ussing chambers
Two sections of proximal small intestine from each NOD-DQ8
mouse were used for Ussing chamber experiments as described
previously [15,19,20]. A 3–4-cm piece of small intestine was
collected (3 cm from the stomach), cut into two sections, and
placed in Krebs buffer aerated with 95% O2 and 5% CO2
(pH 7.3–7.4). Each segment of intestine was cut open along the
mesenteric border to form a flat sheet and mounted into an Ussing
chamber. The chamber exposed 0.7 cm2 of tissue surface area to
8 ml of circulating oxygenated Krebs buffer containing 10 mM
glucose (serosal side) and 10 mM mannitol (mucosal side)
maintained at 37uC. Net active ion transport across the epithelium
was measured via a short circuit current (Isc, mA) injected across
the tissue under voltage-clamp conditions. Tissue conductance (the
passive permeability to ions) was calculated using Ohm’s law.
Baseline Isc (mA/cm2) and conductance (mS/cm2) were recorded
at equilibrium, 20 min after mounting small intestine sections.
Cytokine analysis
The presence of proinflammatory cytokines in serum from
NOD-DQ8 mice was determined using a Cytometric Bead Array
Inflammation kit (BD Biosciences) and analyzed using BD
FACSarray Bioanalyzer System (BD Biosciences).
Real Time PCR
Small Intestinal samples from C57BL/6 and NOD-DQ8 mice
were stored in RNA later in-80uC freezer until be used. Tissues
were disrupted and RNA extraction was performed using RNeasy
Mini Kit (Qiagen). cDNA synthesis was performed from isolated
RNA samples (2-5mg), using iScript Reverse Transcription Super-
mix (Bio-Rad). Real Time PCR reaction was performed with
SsoFast EvaGreen Supermix (Bio-Rad) using the adequate
forward and reverse primers and the iQ5 thermocycler with
fluorescence detection (Bio-Rad). Reactions were run in triplicate.
The Real Time PCR protocol was: Cycle 1 (1X) 95uC for 10min;
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Cycle2 (40X) 60uC for 1min and 95u for 15sec. Primers were
synthesized as it was previously described [21]. The primer
sequences are provided in Table 1. The geometric mean of
housekeeping gene HPRT was used as an internal control to
normalize the variability in expression levels. All results were
expressed as a fold increase of PBS and PIC treatment versus the
mean of PBS treatment in every time point (22DDCt method).
Fluorescence microscopy
Small intestinal sections from PBS- and PIC-treated mice were
deparaffinized and an immunofluorescence protocol was per-
formed. Antigenicity recovery was performed using Antigen
Retrieval AR-10 Solution (BioGenex). After blocking with 2%
goat serum, goat anti-IL-15 IgG antibody (R&D) was added in a
concentration of 2 mg/ml for 1h. Alexa488 donkey anti-goat
antibody (Molecular Probes) in a concentration of 10 mg/ml was
added for 1h. Nuclei were stained with propidium iodide at 1 mg/
ml for 15 minutes. Images were obtained and analyzed in a TCS
SP5 Confocal Microscope combined with Leica LAS AF software.
Statistical analysis
Statistical analysis was performed with GraphPad Prism
software. For more than two treatment groups, an ANOVA with
a Bonferroni post hoc test for multiple comparisons was used.
When two groups were compared, an unpaired t test was used;
p,0.05 was considered significant. Data are displayed as mean
6SEM.
Results
Intraluminal poly I:C induces histological changes in the
small intestinal mucosa
We first evaluated the capacity of poly I:C delivered at the
mucosal site to induce enteropathy in wild type mice. Intraluminal
administration of poly I:C to C57BL/6 mice produced severe
enteropathy. At 12h post poly I:C, we observed shortening and
widening of villi, edema, and increased cell infiltration in the lamina
propria (LP). Using H&E staining edema, dilated capillaries and
interstitial spaces were observed in intestinal villi (Figure 1A).
Furthermore, V/C ratios were decreased, while the number of
IELs and global histological score increased compared to PBS-
treated mice (Figure 1B). At 72h post poly I:C, there was partial
recovery of villus-to-crypt (V/C) ratios. In contrast to control mice,
morphometric parameters remained altered in poly I:C-treated
mice (Figure 1C). As expected, the surgical procedure altered
intestinal histology. However, this change was transient, and
control mice exhibited a faster recovery after treatment. We also
tested whether molecular weight of poly I:Cs influenced inflam-
mation and mucosal damage. We did not detect significant
differences among the tested poly I:Cs (Figure S1), and therefore
the remaining experiments were carried out using the commonly
used commercial poly I:C.
Inflammatory mediators and receptors MDA5, RIGI and
TLR3 are induced by intraluminal poly I:C in small
intestine
We next explored the signaling pathways induced by intralu-
minal poly I:C. For this we analyzed the kinetics of expression of
inflammatory mediators and three receptors for poly I:C in a time-
course experiment using C57BL/6 mice. In the small intestine,
there was a rapid and strong increment of IFNb 2h after
treatment, while CXCL10 and TNFa peaked 4h after intralumi-
nal administration of poly I:C (Figure 2A). Analysis of expression
of proinflammatory cytokines such as IL-18, IL-1b, IL-15 and
IFNc,chemokines such as MCP1 and CXCL2, and anti- and pro-
apoptotic molecules Bcl-2 and Bax, respectively, did not show any
differences between groups (data not shown).Since recognition
of poly I:C is mediated by TLR3, MDA5 and RIGI and their
expressions are modulated by poly I:C, we evaluated whether the
expression of these receptors were induced in the small intestine of
treated mice. The time course experiment showed that MDA5,
RIGI and TLR3 mRNA were similarly upregulated in small
Table 1. Primers used for quantitative PCR.
Gene Forward Reverse
HPRT CAATGCAAACTTTGCTTTCC CAAATCCAACAAAGTCTGGC
MDA5 CGATCCGAATGATTGATGCA AGTTGGTCATTGCAACTGCT
RIG-I CAGACAGATCCGAGACACTA TGCAAGACCTTTGGCCAGTT
TLR3 GAAGATGATGCAGTCTTTCCA CCTGTATCATATTCTACTCCTTGC
IFNb AATGGAAAGATCAACCTCAC AAGGCAGTGTAACTCTTCTG
CXCL10 ATAGGGAAGCTTGAAATCATCC TTCATCGTGGCAATGATCTC
CXCR3 TGTAGTTGGGCTAGCTCGAACTT ACCTGGATATATGCTGAGCTGTCA
TNFa CTCCCTCTCATCAGTTCTATGG TTGAGAAGATGATCTGAGTGTG
IL-15 CATCCATCTCGTGCTACTTGTGTT CATCTATCCAGTTGGCCTCTGTTT
MCP1 CTACAAGAGGATCACCAGCAG TTCTGATCTCATTTGGTTCCG
CXCL2 AAGATACTGAACAAAGGCAAGG TTCTTTCTCTTTGGTTCTTCCG
IL-1b CGTTCCCATTAGACAACTGC CTCATGGAGAATATCACTTGTTGG
IL-18 GATCAAAGTGCCAGTGAACC GATCTTGTTCTTACAGGAGAGG
IL-6 CATGTTCTCTGGGAAATCGT TATATCCAGTTTGGTAGCATCC
IFNc CTGAGACAATGAACGCTACAC TTTCTTCCACATCTATGCCAC
Bax TGCTACAGGGTTTCATCCAG ATTGCTGTCCAGTTCATCTC
Bcl2 GATCTCTGGTTGGGATTCCT ACAACTTGCAATGAATCGGG
doi:10.1371/journal.pone.0099236.t001
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intestine by intraluminal injection of poly I:C. Expression of the
three receptors peaked 6h post-treatment (Figure 2B). Further-
more, we analyzed the protein expression of IL-15, obtaining no
relevant differences among poly I:C and PBS treatments after 12h
(data not shown).
Inflammatory response induced by intraluminal poly I:C
in the small intestine of NOD-DQ8 mice
The NOD-DQ8 mouse represents one useful model of gluten
sensitivity [15]. Nevertheless, the model has particular phenotypes
given by the DQ8 restriction and the NOD background [22].
Thus, prior to gliadin antigen administration, we first examined in
detail the immune responses to poly I:C in NOD-DQ8 mice.
Indeed, poly I:C caused severe mucosal damage in NOD-DQ8
Figure 1. Intraluminal poly I:C induces enteropathy. Representative H&E stained sections of proximal small intestine of C57BL/6 mice after
12hs and 72hs of intraluminal administration of poly I:C or PBS (A). Morphological analysis of small intestine from C57BL/6 mice: villus-to-crypt (V/C)
ratio, number of IELs and histological score after 12h (B) and 72h (C) (Stats: N = 4 mice per group, Unpaired t test, *P,0.05, **P,0.01, ***P,0.001).
doi:10.1371/journal.pone.0099236.g001
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mice characterized by cell infiltration of the LP, edema and
shortening of villi at 12h post-treatment (Figure 3A). Morpho-
metric parameters revealed marked reduction in the V/C ratio in
poly I:C treated NOD-DQ8 mice. Also, IELs numbers and
histological scores were higher in poly I:C-treated mice than in
control NOD-DQ8 mice (Figure 3B).
We found that IFNb mRNA expression was increased in the
small intestinal mucosa of NOD-DQ8 mice at 3h post-poly I:C
compared to controls (Figure 4). A 40-fold increment in CXCL10
mRNA was observed at 3 h in poly I:C-treated mice. At 12 hours,
CXCL10 levels remained higher in poly I:C-treated mice than in
controls. The cytoplasmic pattern recognition receptors for poly
I:C, MDA5 and RIG-I, were also induced in the small mucosa of
poly I:C-treated NOD-DQ8 mice. Expression of both receptors
was increased at 3h, but was higher at 12 h after treatment. The
upregulation of these receptors was observed later than in C57BL/
6 mice. At 3h and 12h post-Poly I:C injection we did not observe
differences in TLR3 expression when compared to PBS controls.
Inflammatory mediators elicited by intraluminal poly I:C were
also evaluated in peripheral blood. Concentration of TNFa, IL-6
and MCP1 was significantly higher 3h after intraluminal admini-
stration of poly I:C than in controls (Figure 5), while IL-10, IL-
12p70 and IFNc did not show changes in poly I:C-stimulated mice
Figure 2. Intraluminal poly I:C generates a proinflammatory response and the induction of MDA5, RIG-I and TLR3 mRNA expression
in small intestine. Real Time-PCR analysis of small intestinal samples from C57BL/6 mice after intraluminal administration of poly I:C or PBS was
performed. Plots shows mRNA expression after 2 to 12h of poly I:C (black dots) or PBS (empty dots) treatment. IFNb, CXCL10, and TNFa mRNA
expression (A). MDA5, RIG-I, and TLR3 mRNA expression (B). All values were normalized with the housekeeping mRNA expression (HPRT). Results were
expressed as fold increase of PBS and poly I:C treatment versus the mean of PBS treatment in every time point (2-DDCt method). Stats: N = 4 mice per
group, Unpaired t test, *P,0.05, **P,0.01, ***P,0.001, poly I:C treated mice versus PBS control in the same time point.
doi:10.1371/journal.pone.0099236.g002
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versus PBS controls (data not shown). Altogether these results
suggest a systemic pro-inflammatory state.
Intraluminal poly I:C and oral dietary antigen induce
prolonged enteropathy in NOD-DQ8 mice
Once we had determined the local and systemic immune
responses of NOD-DQ8 mice to mucosally-administered poly I:C,
we evaluated whether this was potentiated or prolonged by oral
administration of relevant dietary antigen. NOD-DQ8 mice were
treated with poly I:C and fed gliadin or a gluten-free chow,
starting 24h later, three times a week during two weeks. Small
intestinal sections and blood samples were collected after two
weeks. A gluten-free chow did not affect the level of enteropathy in
NOD-DQ8 mice induced by intraluminal poly I:C. H&E staining
showed subepithelial edema and moderate lifting of villi in poly
I:C-treated mice with or without gliadin (Figure 6A).Histological
parameters revealed that both groups had an altered V/C ratio,
but similar IELs counts, 2 weeks after poly I:C administration
(Figure 6B). However, persistent morphological changes in the
small intestinal mucosa were only observed in poly I:C-treated
NOD-DQ8 mice that were subsequently challenged with gliadin,
indicating maintenance of intestinal damage by oral antigen
administration.
We also evaluated intestinal barrier function by Ussing chamber
technique. Oral gavage of gliadin for two weeks was associated
with increased transepithelial conductance in poly I:C-treated
NOD-DQ8 mice. This change was not observed in poly I:C-
treated mice fed a gluten free chow or in control mice (Figure
7A).The evaluation of isotopic flux of 51Cr-EDTA showed
increased paracellular permeability two weeks after poly I:C
treatment regardless of the diet. However the percentage increase
was higher in mice receiving gliadin gavages than in those on
gluten-free chow (mean value for each treatment: PBS-GFD:
0.095%, poly I:C-GFD: 0.22%, PBS-gliadin: 0,17%, poly I:C-
Gliadin: 0,56% Hot/h/cm2). The levels of the proinflammatory
cytokines IL-12p70 and TNFa were increased in peripheral blood
of mice gavaged with gliadin after 2 weeks compared with those
on gluten free chow, even in the absence of poly I:C treatment
(Figure 7B). However no differences were observed in MCP-1,
IL-6 and IFNc cytokine production in any of groups (data not
shown). Gliadin gavages also induced an increment in the anti-
inflammatory cytokine IL-10 in serum. Remarkably, poly I:C
treatment abolished the production of IL-10 induced by gliadin.
Figure 3. Intraluminal administration of poly I:C induces enteropathy in NOD-DQ8 mice. Representative H&E-stained sections of the
proximal small intestine in PBS and poly I:C-treated NOD-DQ8 mice at 12h post-treatment (A). Morphological analysis of small intestine from NOD-DQ8
mice: villus-to-crypt (V/C) ratio, number of IELs and histological score after 12h. Stats: N = 4 mice per group, Unpaired t test, *P,0.05, **P,0.01 (B).
doi:10.1371/journal.pone.0099236.g003
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Therefore, orally delivered gliadin in poly I:C treated mice
produced a substantial imbalance in the IL-12p70/IL-10 ratio,
suggesting a long lasting proinflammatory milieu. Serum levels of
IL-12p70 and IL-10 were below the limit of detection in mice on
gluten-free chow. These results suggest that local inflammatory
and functional processes in the small intestine induced by
intraluminal poly I:C predispose to stronger functional impair-
ment and inflammatory response to a relevant orally-administered
dietary antigen.
Discussion
We showed that induction of local small intestinal inflammation
can be elicited by intraluminal administration of poly I:C to both
wild type and gliadin-sensitive NOD-DQ8 mice. We determined
that the severe enteropathy induced by intraluminal poly I:C,
predisposed to functional impairment of small intestine in NOD-
DQ8 mice receiving the dietary antigen, gliadin.
During viral enteric infections, intermediates of replication, such
as dsRNA, are produced in infected cells [6] and trigger a rapid
inflammatory cascade, which involves the activation of TLR3 and
RNA helicases such as RIG-I and MDA5 [7]. Poly I:C is a
synthetic analogue commonly used to mimic the effects of dsRNA
Figure 4. Poly I:C generates a proinflammatory response and induces RIG-I and MDA5 mRNA expression in the small intestine from
NOD-DQ8 mice. Real Time-PCR analysis of the IFNb, CXCL10, TLR3, MDA5, and RIG-I mRNA expression at 3 and 12 h post-treatment with poly I:C
(black bar) or PBS (white bar). All values were normalized to the housekeeping mRNA expression (HPRT). All results were expressed as a fold increase
of PBS and poly I:C treatment versus the mean of PBS treatment in every time point (22DDCt). Stats: N = 4 mice per group, Unpaired t test, *P,0.05,
**P,0.01, poly I:C-treated mice versus PBS control in the same time point.
doi:10.1371/journal.pone.0099236.g004
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which causes intestinal pathology when injected parentally [2,3,4].
The marked villus shortening and increased enterocyte apoptosis
observed after parenteral poly I:C has been suggested to be caused
by TLR3/TRIF/Caspase 8 activation[5]. We used instead
intraluminal administration of poly I:C and demonstrated it
produced severe intestinal pathology, as assessed by reduced V/C
ratio, increased IELs counts and increased global histological
scores. Induction of dsRNA sensors TLR3, MDA5 and RIG-I was
transient, peaked at 6h and returned to basal levels at 12h. In
previous models using parenteral poly I:C administration, mucosal
damage seemed to be specific for TLR3 activation[3,4,5]. The
underlying mechanisms proposed for intestinal damage include
NK cells [2] and CD8aa+ IELs with critical participation of IL-15
[3,4]. A recent study however has proposed that, neither NK cells,
IELs or IL-15 are involved in the induction of intestinal pathology
[5]. Using intraluminal poly I:C, we found a strong and early
increase of IFNb mRNA levels in the small intestine of C57BL/6
mice 2h post-treatment, indicating a mucosal specific poly I:C-
signaling activation. TNFa, a cytokine commonly involved in the
early inflammatory response, was also transiently upregulated.
Remarkably, a 60-fold increase in CXCL10 expression was
observed 4h after intraluminal poly I:C. CXCL10 has previously
been shown to be upregulated by poly I:C in different
experimental strategies[23], and it may play a crucial role in the
development of small intestine pathology since it is a major chemo-
attractant for Th1 CXCR3+ cells into inflamed tissues [24,25].
The mRNA expression of proinflammatory cytokines such as
IL-15, IL-18, IL-1b and IFNc, chemokines such as MCP1 and
CXCL2 and anti- and pro-apoptotic molecules as Bcl-2 and Bax
respectively, were analyzed, but no changes were observed (data
not shown). This is consistent with the report by McAllister C.
et al. [5] using a parenteral poly I:C model.
Since poly I:C triggers a cascade of inflammatory reactions
involving different signaling pathways some of the effects after poly
I:C administration may also have diverse origins. The observation
that transglutaminase 2 (TG2) is activated in small intestine by
intraperitoneal poly I:C administration highlights that different
players may contribute to additional dysregulation of gut
homeostasis[26]. Upregulation of TG2 has also been related to
NFkB pathway, driving an amplification loop of inflammation and
damage at the small intestinal mucosa[27]. Overall our results
suggest that intraluminal poly I:C induces rapid mucosal immune
activation involving IFNb, and the CXCL10/CXCR3 axis that
may drive inflammation towards a Th1 profile.
Understanding the early and delayed consequences of immune
activation by enteric viral infections, or dsRNA, has important
implications for post-infectious inflammatory and functional
consequences [10]. Thus our second aim was to determine
whether a single intraluminal administration of poly I:C influenced
subsequent responses to gliadin, a dietary antigen that causes CD
in genetically susceptible people, but which may be involved in gut
functional abnormalities in a subgroup of patients with irritable
bowel syndrome (non celiac gluten sensitivity) [28]. For this we
used NOD-DQ8 mice, which lack all endogenous class II
molecules and express the human HLA-DQ8 gene involved in
CD [16,29]. Previous studies using this model have shown that
gliadin sensitization results in barrier dysfunction and moderate
enteropathy [15]. Poly I:C-treated NOD-DQ8 mice developed
mucosal damage characterized by higher histological score than in
control mice, cell infiltration in LP, reduction of V/C ratio,
increased IEL counts, and upregulation of IFNb and CXCL10
mRNA in intestinal mucosa. This was also accompanied by higher
levels of TNFa, IL-6 and MCP1 in peripheral blood. After poly
I:C administration, one group of NOD-DQ8 mice was subjected
to oral gliadin challenges while another was fed a gluten free chow.
51Cr-EDTA flux studies indicated increased paracellular perme-
ability in poly I:C-treated mice after two weeks regardless of the
dietary treatments. Poly I:C also induced alterations in V/C ratio
compared to control mice in both gliadin challenged and gluten
free mice. However, only poly I:C-treated mice receiving gliadin
presented higher global histological scores, demonstrating severe
changes in the mucosa. More importantly, increased transepithe-
lial conductance was only observed in poly I:C-treated NOD-DQ8
mice that were subsequently challenged with gliadin. Remarkably,
after two weeks of gliadin ingestion, NOD-DQ8 mice showed
increased levels of the proinflammatory cytokines IL-12p70 and
TNFa in peripheral blood, compared with those on gluten-free
chow, indicating a causal link to gliadin challenges and not to poly
Figure 5. Increased serum levels of TNFa, MCP-1, and IL-6 after
intraluminal poly I:C administration. TNFa, MCP-1, and IL-6
concentration was assessed in serum after 3h of poly I:C or PBS
treatment, using a cytometric bead array inflammation kit. The dotted
line represents the limit of detection. Stats: N = 4 mice per group,
Unpaired t test, *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0099236.g005
Intraluminal Poly I:C Causes Gluten Enteropathy
PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e99236
I:C treatment. Moreover, IL-10 induction by gliadin, a feature
observed in -DQ8 mouse models of gluten sensitivity before
[15,30,31], was inhibited in previously poly I:C-treated mice. An
imbalance in the IL-12p70/IL-10 ratio was observed in gliadin
challenged and poly I:C-treated NOD-DQ8 mice. The inflam-
matory effects elicited by IL-12p70 and TNFa have been shown to
have direct effects on barrier function and intestinal damage. The
correct assembly of tight junction components is critical to
preserve barrier integrity and TNFa is recognised as one of the
main mediators associated with inflammation in Crohn’s disease
and CD. TNFa signalling activates myosin light chain kinase
(MLCK) and tight junction remodelling leading to loss of barrier
function [32,33]. It is noteworthy that gliadin peptides can also
increase permeability by innate mechanisms amplifying the circuit
of mucosal damage [34,35,36,37].
Figure 6. Gliadin induces histological damage in intraluminal poly I:C-treated NOD-DQ8 mice. Representative H&E-stained sections of
the proximal small intestine from PBS and poly I:C-treated NOD-DQ8 mice on a gluten free diet (GFD) or orally gavaged with gliadin during 2 weeks
(A). Morphological analysis of small intestine from NOD-DQ8 mice treated with poly I:C or PBS under a gluten free diet (GFD) or gavaged with gliadin
during 2 weeks: V/C ratio, number of IELs and histological score. Stats: N = 4-5 mice per group, Unpaired t test, **P,0.01, ***P,0.001 (B).
doi:10.1371/journal.pone.0099236.g006
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We did not observe changes in IL-15 expression associated with
this model. IL-15 expression has a complex post-transcriptional
control which is particularly important to maintain an adequate
balance of the immune response in gut. Remarkably, IL-15
expression has been shown to be modulated by p31-43 gliadin
peptide, which triggers different innate responses in Caco-2 cells as
well as in human duodenum [38]. Though we did not specifically
work with p31-43, we have performed significant characterization
Figure 7. Gliadin induces barrier dysfunction and proinflammatory cytokines in poly I:C-treated NOD-DQ8 mice. After 24h of the final
gavage, sections of small intestine were mounted in Ussing chambers and tissue conductance (mS/cm2) and isotopic flux (% Hot/h/cm2) were
measured. Each dot represents an individual mouse and is a mean of 2 independent tissues. Stats: N = 3-4 mice per group, Two way ANOVA and
Bonferroni post-test, *P,0.05 (A). Analysis of IL-12p70, TNFa and IL-10 in serum samples from poly I:C or PBS-treated mice on a gluten-free diet (GFD)
or gavaged with gliadin for 2 weeks. IL-12p70/IL-10 ratio was determined. Serum concentration of cytokines was determined by a cytometric bead
array inflammation kit. The dotted line represents the limit of detection. Stats: N = 4-5 mice per group, Two way ANOVA and Bonferroni post-test,
*P,0.05, **P,0.01 gliadin versus GFD mice; #P,0.05 poly I:C versus PBS in Gliadin-gavaged mice (B).
doi:10.1371/journal.pone.0099236.g007
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of the NOD-DQ8 model [15].Given the NOD background of
mice this model is not specifically IL-15 driven. Thus, neither
mRNA nor protein IL-15 determinations in this particular model
are useful markers.
In conclusion, intraluminal poly I:C induced a severe but
transitory damage in the small intestinal mucosa in both wild-type
and NOD-DQ8 mice.The combination of poly I:C and subse-
quent gliadin feeding in the genetically susceptible mouse strain
NOD-DQ8, led to a proinflammatory synergistic effect and
impairment of gut barrier function. Our results raise the intriguing
hypothesis thattype I IFNs constitute an important contributor to
the loss of tolerance to dietary antigens such as gluten, after a viral
infection. This may be particularly important in genetically
susceptible hosts, by promoting inflammation as well as a biased
Th1 response. We hypothesize that this may provide a mechanistic
explanation for the clinical link between enteric infections and
post-inflammatory and functional disorders [11,12,39,40,41].
Supporting Information
Figure S1 Different molecular weight poly I:Cs cause enterop-
athy. Analysis of different molecular weight poly I:Cs by ethidium
bromide-stained agarose gel electrophoresis, commercial poly I:C
(PICs) (Sigma-Aldrich), PICL (LMW-PIC) and PICH (HMW-PIC)
(Invivogen) (A). Morphological analysis performed in C57BL/6
mice intraluminally treated with PICs, PICL or PICH in a time-
course experiment (from 12 up to 72hs) (B): V/C ratio vs. time (i);
V/C ratio at 72h post-treatment with different poly I:Cs or PBS
(ii); Histological score at 12h and 72h after different poly I:Cs
treatments (iii). (Stats: N= 4 mice per group, Unpaired t test,
*P,0.05, **P,0.01, ***P,0.001).
(TIF)
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